ELIXIR DIAGNOSTICS LLC NPI 1932843836

NPI Details

ELIXIR DIAGNOSTICS, LLC is a clinical medical laboratory in Houston, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. ELIXIR DIAGNOSTICS, LLC NPI is 1932843836. The provider is registered as an organization entity type.

The provider's business location address is:

17115 RED OAK DR STE 123
HOUSTON, TX
ZIP 77090-607
Phone: (979) 487-8258
Fax: (832) 413-0059

The provider's authorized official is Ali Siddiqui .
The authorized official title is Owner and has the following contact phone number (561) 635-0392.

The CLIA number assigned to this NPI record is 45D2257672 - independent with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Molecular pathology procedure level 1 (HCPCS:81400)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants (HCPCS:81291)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 9) common variants (HCPCS:81227)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant (HCPCS:81328)

The enumeration date for this NPI number is 4/26/2022 and was last updated on 4/26/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: